Nutritional essentiality of sulfur in health and disease

Nutrition Reviews

Volumn 71, Issue 7, 2013, Pages 413-432

  Ingenbleek, Yves ^a   Kimura, Hideo ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Developing countries; Elemental sulfur; Hydrogen sulfide; Hyperhomocysteinemia; Malnutrition; Methionine; Oxidative stress; Stressful disorders; Transthyretin; Veganism

Indexed keywords

AMINO ACID; ANDROSTENEDIONE; CALCIUM; CARBON; CARBON DIOXIDE; CATECHOLAMINE; CHOLECYSTOKININ; CYSTEINE; ESTRADIOL; GASTRIN; GLUTATHIONE; GONADOTROPIN; HYDROCORTISONE; HYDROGEN; HYDROGEN PEROXIDE; METHIONINE; NITRATE; NITRITE; NITROGEN; OXYGEN; PHOSPHORUS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SULFATE; SULFUR; SULFUR AMINO ACID; TESTOSTERONE; UNINDEXED DRUG;

ALLOSTERISM; ARTICLE; AUTOTROPHY; BIOGENESIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHLOROPLAST; CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; DRUG HALF LIFE; ENZYME SYNTHESIS; ESTERIFICATION; EXTRACELLULAR MATRIX; FOOD INTAKE; HEALTH; HETEROTROPHY; HORMONE BLOOD LEVEL; HUMAN; HYDROLYSIS; HYPERHOMOCYSTEINEMIA; MALNUTRITION; MOLECULAR WEIGHT; MORBIDITY; NONHUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PHOTOSYNTHESIS; PHYSICAL CHEMISTRY; PLANT; PROTEIN METHYLATION; PROTEIN SYNTHESIS; RISK FACTOR; SIGNAL TRANSDUCTION; SOYBEAN; VEGETABLE;

DEVELOPING COUNTRIES; ELEMENTAL SULFUR; HYDROGEN SULFIDE; HYPERHOMOCYSTEINEMIA; MALNUTRITION; METHIONINE; OXIDATIVE STRESS; STRESSFUL DISORDERS; TRANSTHYRETIN; VEGANISM;

AMINO ACIDS, ESSENTIAL; CARDIOVASCULAR DISEASES; DIETARY PROTEINS; HUMANS; METHIONINE; OXIDATION-REDUCTION; STROKE; SULFUR;

ANIMALIA;

EID: 84879839976     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12050     Document Type: Article

References (293)

1. Forbes GB. Body composition. In: Ziegler EE, Filer LJ, eds. Present Knowledge in Nutrition, 7th ed. Washington, DC: ILSI Press; 1996:7-12.
2. Davidson S, Meiklejohn AP, Passmore R. Human Nutrition and Dietetics. Edinburgh & London: Livingstone ES; 1959.
3. Coleman R. The importance of sulfur as a plant nutrient in world crop production. Soil Sci. 1966;101:230-239.
4. Dijkshoorn W, van Wijk AL. The sulphur requirements of plants as evidenced by the sulphur-nitrogen ratio in the organic matter. A review of published data. Plant Soil. 1967;26:129-157.
5. Jez JM. Sulfur: A Missing Link between Soils, Crops, and Nutrition. Madison, WI: American Society of Agronomy, Crop Science Society of America, Soil Science Society of America; 2008. Monograph 50.
6. Fageria NK, Baligar VC, Jones CA. Growth and Mineral Nutrition of Field Crops. London: Taylor & Francis; 2010.
7. Huxtable RJ. Biochemistry of Sulfur. New York: Plenum Press; 1986.
8. Ingenbleek Y. The nutritional relationship linking sulfur to nitrogen in living organisms. J Nutr. 2006;136(Suppl 6):S1641-S1651.
9. Nickless G. Inorganic Sulfur Chemistry. Amsterdam, The Netherlands: Elsevier; 1968.
10. Holland HD. Aspects of the geologic history of seawater. Orig Life. 1974;5:87-91.
11. Ault WV, Kulp JL. Isotopic geochemistry of sulphur. Geochim Cosmochim Acta. 1959;16:201-235.
12. Kelly DP. The sulphur cycle: definition, mechanisms and dynamics. In: Elliot K, Whelan J, eds. Sulphur in Biology. CIBA Foundation Symposium No. 72, Amsterdam, The Netherlands: Excerpta Medica; 1980:3-18.
13. Mitchell SC. Biological Interactions of Sulfur Compounds. London: Taylor & Francis; 1996.
14. Mohr H, Schopfer P. Plant Physiology. Berlin: Springer Verlag; 1994.
15. Bothe H, Trebst A. Biology of Inorganic Nitrogen and Sulfur. Berlin: Springer Verlag; 1981.
16. Miflin BJ, Lea PJ. Amino acid metabolism. Annu Rev Plant Physiol. 1977;28:299-329.
17. Amir R, Hacham Y. Methionine metabolism in plants. In: Jez JM, ed. Sulfur, a Missing Link between Soils, Crops, and Nutrition. Madison, WI: American Society of Agronomy, Crop Science Society of America, Soil Science Society of America; 2008:251-279. Monograph 50.
18. Schwenn JD, Urlaub H. Recent results on the assimilatory sulfate reduction: APS-kinase and the reduction of APS to cysteine in higher plants. In: Bothe H, Trebst A, eds. Biology of Inorganic Nitrogen and Sulfur. Berlin: Springer Verlag; 1981:334-340.
19. Laidlaw SA, Shultz TD, Cecchino JT, etal. Plasma and urine taurine levels in vegans. Am J Clin Nutr. 1988;47:660-663.
20. Roje S. S-Adenosyl-L-methionine: beyond the universal methyl group donor. Phytochemistry. 2006;67:1686-1698.
21. Eckermann C, Eichel J, Schröder J. Plant methionine synthase: new insights into properties and expression. Biol Chem. 2000;381:695-703.
22. Ravanel S, Gakière B, Job D, etal. The specific features of methionine biosynthesis and metabolism in plants. Proc Natl Acad Sci U S A. 1998;95:7805-7812.
23. Mills WR. Photosynthetic formation of the aspartate family of amino acids in isolated chloroplasts. Plant Physiol. 1980;65:1166-1172.
24. Eaton SV. Sulphur content of seeds and seed weight in relation to effects of sulphur deficiency on growth of sunflower plants. Plant Physiol. 1942;17:422-434.
25. Mertz ET, Matsumoto H. Further studies on the amino acids and proteins of sulfur-deficient alfalfa. Arch Biochem Biophys. 1956;63:50-63.
26. Lunde C, Zygadlo A, Simonsen HT, etal. Sulfur starvation in rice: the effect on photosynthesis, carbohydrate metabolism and oxidative stress protective pathways. Physiol Plant. 2008;134:508-521.
27. Khrisnan HB. Improving the S-containing amino acids of soybean to enhance its nutritional value in animal feed. In: Jez JM, ed. Sulfur: A Missing Link between Soils, Crops and Nutrition. Madison, WI: American Society of Agronomy, Crop Science Society of America, Soil Science Society of America; 2008:235-250. Monograph 50.
28. Friedrich JW, Schrader LE. Sulfur deprivation and nitrogen metabolism in maize seedlings. Plant Physiol. 1978;61:900-903.
29. Naeem HA. Sulfur nutrition and wheat quality. In: Jez JM, ed. Sulfur: A Missing Link between Soils, Crops, and Nutrition. Madison, WI: American Society of Agronomy, Crop Science Society of America, Soil Science Society of America; 2008:153-170. Monograph 50.
30. Ingenbleek Y. Plasma transthyretin reflects the fluctuations of lean body mass in health and disease. In: Richardson SJ, Cody V, eds. Recent Advances in Transthyretin Evolution, Structure and Biological Functions. Berlin: Springer Verlag; 2009:329-357.
31. Ingenbleek Y, Young VR. Significance of transthyretin in protein metabolism. Clin Chem Lab Med. 2002;40:1281-1291.
32. Sherman HC, Hawk PB. On the elimination of nitrogen, sulphates, and phosphates after the ingestion of proteid food. Am J Physiol. 1900;4:25-49.
33. Ingenbleek Y. Hyperhomocysteinemia is a biomarker of sulfur-deficiency in human morbidities. Open Clin Chem J. 2009;2:49-60.
34. Fahey RC, Hunt JS, Windham GC. On the cysteine and cystine content of proteins. Differences between intracellular and extracellular proteins. J Mol Evol. 1977;10:155-160.
35. Hofman K, Hamm R. Sulfhydryl and disulfide groups in meats. Adv Food Res. 1978;24:1-111.
36. Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711-760.
37. Beutler E. Nutritional and metabolic aspects of glutathione. Annu Rev Nutr. 1989;9:287-302.
38. Taniguchi M, Hirayama K, Yamaguchi K, etal. Nutritional aspects of glutathione metabolism and function. In: Dolphin D, Poulson R, Avramovic O, eds. Glutathione: Chemical, Biological and Medical Aspects. New York: J. Wiley & Sons; 1989:645-727.
39. Ingenbleek Y, McCully KS. Vegetarianism produces subclinical malnutrition, hyperhomocysteinemia and atherogenesis. Nutrition. 2012;28:148-153.
40. Young VR, Pellet PL. Current concepts concerning amino acids in adults and their implications for international planning. Food Nutr Bull. 1990;12:289-300.
41. Young VR, Puig M, Queiroz E, etal. Evaluation of the protein quality of an isolated soy protein in young men: relative nitrogen requirements and effect of methionine supplementation. Am J Clin Nutr. 1984;39:16-24.
42. Mueller JH. A new sulphur-containing amino acid isolated from hydrolytic products of protein. J Biol Chem. 1923;56:157-169.
43. Womack M, Kemmerer KS, Rose WC. The relation of dietary methionine and cysteine to growth. J Biol Chem. 1937;121:403-410.
44. Rose WC, Wixom RL. The amino acid requirements of man. XIII. The sparing effect of cysteine on the methionine requirement. J Biol Chem. 1955;216:753-773.
45. Rose WC. The amino acid requirements of adult man. Nutr Abstr Rev. 1957;27:631-647.
46. Raguso CA, Ajami AM, Gleason R, etal. Effect of cysteine intake on methionine kinetics and oxidation determined with oral tracers of methionine and cystine in healthy adults. Am J Clin Nutr. 1997;66:283-292.
47. Ball RO, Courtney-Martin G, Pencharz PB. The in vivo sparing of methionine by cysteine in sulfur amino acid requirements in animal models and adult humans. J Nutr. 2006;136(Suppl 6):S1686-S1693.
48. Di Buono M, Wykes LJ, Cole DE, etal. Regulation of sulfur amino acid metabolism in man in response to changes in sulfur amino acid intakes. J Nutr. 2003;133:733-739.
49. Young VR, Yu YM, Fukagawa NK, etal. Methionine kinetics and balance. In: Graham I, Refsum H, Rosenberg IH, etal., eds. International Conference on Homocysteine Metabolism: From Basic Science to Clinical Medicine. Norwell, MA: Kluwer Academic; 1997:11-22.
50. Gaull G, Sturman JA, Raïhä NC. Development of mammalian sulfur metabolism: absence of cystathionase in human fetal tissues. Pediatr Res. 1972;6:538-547.
51. Viña T, Vento M, Garciá-Sala F, etal. L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionine deficiency. Am J Clin Nutr. 1995;61:1067-1069.
52. McNally ME, Atkinson SA, Cole DE. Contribution of sulfate and sulfoesters to total sulfur intake in infants fed human milk. J Nutr. 1991;121:1250-1254.
53. Lemons JA, Reyman D, Moye L. Amino acid composition of preterm and term breast milk during early lactation. Early Hum Dev. 1983;8:323-329.
54. Pohlandt F. Cystine: a semi-essential amino acid in the newborn infant. Acta Paediatr Scand. 1974;63:801-804.
55. Griffiths OW. Mammalian sulfur amino acid metabolism: an overview. Methods Enzymol. 1987;143:366-376.
56. FAO/WHO/UNU. Energy and Protein Requirements. Report of a Joint FAO/WHO/UNU Expert Consultation Group. WHO Technical Report Series No. 724. Geneva: World Health Organization; 1985.
57. Young VR, Borgonha S. Nitrogen and amino acid requirements: the Massachusetts Institute of Technology amino acid requirement pattern. J Nutr. 2000;130:S1841-S1849.
58. Institute of Medicine. Dietary Reference Intakes. Energy, Carbohydrate, Fiber, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: National Academic Press; 2000.
59. Magee EA, Curno R, Edmond LM, etal. Contribution of dietary protein and inorganic sulfur to urinary sulfate: toward a biomarker of inorganic sulfur intake. Am J Clin Nutr. 2004;80:137-142.
60. Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr. 2004;24:539-577.
61. Stabler SP, Marcell PD, Podell ER, etal. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem. 1987;162:185-196.
62. Weight JB, Martin PG, Skellenger ML, etal. Metabolic patterns in preadolescent children. III. Sulfur balance on three levels of nitrogen intake. J Nutr. 1960;72:314-316.
63. Sabry ZI, Shadarevian SB, Cowan JW, etal. Relationship of dietary intake of sulphur amino-acids to urinary excretion of inorganic sulphate in man. Nature. 1965;206:931-933.
64. Jones DP, Coates RJ, Flagg EW, etal. Glutathione in foods listed in the National Cancer Institute's Health Habits and History Food Frequency Questionnaire. Nutr Cancer. 1992;17:57-75.
65. Fürst P. Intracellular muscle free amino acids - their measurement and function. Proc Nutr Soc. 1983;42:451-462.
66. Bauer JH. Oral administration of radioactive sulfate to measure extracellular fluid space in man. J Appl Physiol. 1976;40:648-650.
67. Florin T, Neale G, Gibson GR, etal. Metabolism of dietary sulphate: absorption and excretion in humans. Gut. 1991;32:766-773.
68. Hoffman DA, Wallace SM, Verbeeck RK. Circadian rhythm of serum sulfate levels in man and acetaminophen pharmacokinetics. Eur J Clin Pharmacol. 1990;39:143-148.
69. Hoffer J, Hamadeh MJ, Robitaille L, etal. Human sulfate kinetics. Am J Physiol Regul Integr Comp Physiol. 2005;289:R1372-R1380.
70. Walser H, Seldin DW, Grollman A. An evaluation of radiosulfate for the determination of the volume of extracellular fluid in man and dogs. J Clin Invest. 1953;32:299-311.
71. Becker EL, Heinemann HO, Igarashi K, etal. Renal mechanisms for the excretion of inorganic sulfate in man. J Clin Invest. 1960;39:1909-1913.
72. Boström H, Vestermark A. Studies on ester sulphates. 9. On the occurrence of sulphate acceptors in human urine. Scand J Clin Lab Invest. 1960;12:323-328.
73. Langer P, Greer MA. Antithyroid Substances and Naturally Occurring Goitrogens. Basel: Karger; 1977.
74. Florin T, Neale G, Goretski S, etal. The sulfate content of foods and beverages. J Food Comp Anal. 1993;6:140-151.
75. Le Bon AM, Sies MH. Organosulfur compounds from allium and the chemoprevention of cancer. Drug Metabol Drug Interact. 2000;17:51-79.
76. Benavides GA, Squadrito GL, Mills RW, etal. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A. 2007;104:17977-17982.
77. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J Biol Chem. 1984;259:9508-9513.
78. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Adaptation to methionine excess. J Biol Chem. 1986;261:1582-1587.
79. Stipanuk MH, Ueki I. Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur. J Inherit Metab Dis. 2011;34:17-32.
80. Durando X, Thivat E, Gimbergues P, etal. Methionine dependency of cancer cells: a new therapeutic approach? Bull Cancer. 2008;95:69-76.
81. Cavuoto P, Fenech MF. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat Rev. 2012;38:726-736.
82. Ittyerah TR. Urinary excretion of sulfate in kwashiorkor. Clin Chim Acta. 1969;25:365-369.
83. Rudland PS, Clark BFC. Polypeptide chain initiation and the role of a methionine tRNA. In: Bosch L, ed. The Mechanism of Protein Synthesis and Its Regulation. Amsterdam: North-Holland Publishing Co.; 1972:55-131.
84. Brosnan JT, Brosnan ME, Bertolo RFP, etal. Methionine: a metabolically unique amino acid. Livest Sci. 2007;112:2-7.
85. Giulidori P, Galli-Kienle M, Catto E, etal. Transmethylation, transsulfuration, and aminopropylation reactions of S-adenosyl-L-methionine in vivo. J Biol Chem. 1984;259:4205-4211.
86. Finkelstein JD, Kyle WE, Harris BJ. Methionine metabolism in mammals: regulation of homocysteine methyltransferases in rat tissues. Arch Biochem Biophys. 1971;146:84-92.
87. Finkelstein JD, Kyle WE, Martin JJ, etal. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. Biochem Biophys Res Commun. 1975;66:81-87.
88. Banerjee RV, Matthews RG. Cobalamin-dependent methionine synthase. FASEB J. 1990;4:1450-1459.
89. 667 T polymorphism. Clin Chem. 2000;46:1065-1071.
90. Finkelstein JD. Inactivation of betaine-homocysteine methyltransferase by adenosylmethionine and adenosylhomocysteine. Biochem Biophys Res Commun. 1984;118:14-19.
91. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr. 1998;157(Suppl 2):S40-S44.
92. Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost. 2000;26:219-225.
93. Meier M, Janosik M, Kery V, etal. Structure of human cystathionine-β-synthase: a unique pyridoxal 5′-phosphate-dependent heme protein. EMBO J. 2001;20:3910-3916.
94. Jhee KH, Kruger WD. The role of cystathionine β-synthase in homocysteine metabolism. Antioxid Redox Signal. 2005;7:813-822.
95. Cooper AJL. Biochemistry of sulfur-containing amino acids. Annu Rev Biochem. 1983;52:187-222.
96. 3] methionine kinetics in humans: methionine conservation and cystine sparing. Am J Physiol. 1990;258:E790-E798.
97. Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism. 1975;24:721-735.
98. Kutzbach C, Stokstad EL. Feedback inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosylmethionine. Biochim Biophys Acta. 1967;139:217-220.
99. Fukagawa NK, Yu YM, Young VR. Methionine-cysteine kinetics at different intakes of methionine and cysteine in elderly men and women. Am J Clin Nutr. 1998;68:380-388.
100. Stegink LD, Den Besten L. Synthesis of cysteine from methionine in normal adult subjects: effect of route of alimentation. Science. 1972;178:514-516.
101. Bauchart-Thevret C, Stoll B, Burrin DG. Intestinal metabolism of sulfur amino acids. Nutr Res Rev. 2009;22:175-187.
102. Van Klinken BJ, Einerhand AW, Büller HA, etal. Strategic biochemical analysis of mucins. Anal Biochem. 1998;265:103-116.
103. Riedijk MA, Stoll B, Chacko S, etal. Methionine transmethylation and transsulfuration in the piglet gastrointestinal tract. Proc Natl Acad Sci U S A. 2007;104:3408-3413.
104. Bauchart-Thevret C, Stoll B, Chacko S, etal. Sulfur amino acid deficiency upregulates intestinal methionine cycle activity and suppresses epithelial growth in neonatal pigs. Am J Physiol Endocrinol Metab. 2009;296:E1239-E1250.
105. Barbezat GO, Bowie MD, Kaschula RO, etal. Studies on the small intestinal mucosa of children with protein-calorie malnutrition. S Afr Med J. 1967;41:1031-1036.
106. Ingenbleek Y, Young VR. The essentiality of sulfur is closely related to nitrogen metabolism: a clue to hyperhomocysteinemia. Nutr Res Rev. 2004;17:135-151.
107. Betz SF. Disulfide bonds and the stability of globular proteins. Protein Sci. 1993;2:1551-1558.
108. Lyle S, Stanczak J, Ng K, etal. Rat chondrosarcoma ATP sulfurylase and adenosine 5′-phosphosulfate kinase reside on a single bifunctional protein. Biochemistry. 1994;33:5920-5925.
109. Strott CA. Sulfonation and molecular action. Endocr Rev. 2002;23:703-732.
110. Fukuda M, Hiraoka N, Akama TO, etal. Carbohydrate-modifying sulfotransferases: structure, function and pathophysiology. J Biol Chem. 2001;276:47747-47750.
111. Vos JP, Lopes-Cardozo M, Gadella BM. Metabolic and functional aspects of sulfogalactolipids. Biochim Biophys Acta. 1994;1211:125-149.
112. Kjéllen L, Lindhahl U. Proteoglycans: structures and interactions. Annu Rev Biochem. 1991;60:443-475.
113. Nagata K, Yamazoe Y. Pharmacogenetics of sulfotransferase. Annu Rev Pharmacol Toxicol. 2000;40:159-176.
114. Niehrs C, Beisswanger R, Huttner WB. Protein tyrosine sulfation, 1993 - an update. Chem Biol Interact. 1994;92:257-271.
115. Nlend MC, Cauvi D, Venot N, etal. Thyrotropin regulates tyrosine sulfation of thyroglobulin. Eur J Endocrinol. 1999;141:61-69.
116. Visser TJ. Role of sulfate in thyroid hormone sulfation. Eur J Endocrinol. 1996;134:12-14.
117. 2 zinc finger proteins. Annu Rev Biochem. 2001;70:313-340.
118. Combs GF Jr. The Vitamins. Fundamental Aspects in Nutrition and Health, 4th ed. New York: Academic Press; 2012.
119. Gubler CJ. Thiamin. In: Machlin LJ, ed. Handbook of Vitamins, 2nd ed. New York: Marcel Dekker; 1991:233-281.
120. Zempleni J, Mock DM. Biotin biochemistry and human requirements. J Nutr Biochem. 1999;10:128-138.
121. Bremner I, Beattie JH. Metallothionein and the trace minerals. Annu Rev Nutr. 1990;10:63-83.
122. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999;20:761-787.
123. Hoshi T, Heinemann SH. Regulation of cell function by methionine oxidation and reduction. J Physiol. 2001;531:1-11.
124. Stadtman ER, Moskowitz J, Berlett BS, etal. Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol Cell Biochem. 2002;234/235:3-9.
125. Lim JC, You Z, Kim G, etal. Methionine sulfoxide reductase A is a stereospecific methionine oxidase. Proc Natl Acad Sci U S A. 2011;108:10472-10477.
126. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111-128.
127. Ubbink JB, van der Merwe A, Delport R, etal. The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest. 1996;98:177-184.
128. Kang SS, Wong PW, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 1987;36:458-462.
129. Stabler SP, Allen RH, Savage DG, etal. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990;76:871-881.
130. Yan SK, Chang T, Wang H, etal. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun. 2006;351:485-491.
131. Cheng Z, Yang X, Wang H. Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev. 2009;5:158-165.
132. Packer L, Cadenas E. Oxidants and antioxidants revisited. New concepts of oxidative stress. Free Radic Res. 2007;41:951-952.
133. Bautista LE, Arenas IA, Peñuela A, etal. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol. 2002;55:882-887.
134. Furie KL, Kelly PJ. Homocyst(e)ine and stroke. Semin Neurol. 2006;26:24-32.
135. Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol. 1993;40:230-235.
136. McCaddon A, Davies G, Hudson P, etal. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry. 1998;13:235-239.
137. Troen AM, Rosenberg IH. Homocysteine and cognitive function. Semin Vasc Med. 2005;5:209-214.
138. Danese S, Sgambato A, Papa A, etal. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol. 2005;100:886-895.
139. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, etal. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350:2033-2041.
140. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr. 2005;82:806-812.
141. 12 deficiency as a worldwide problem. Annu Rev Nutr. 2004;24:299-328.
142. Hung CJ, Huang PC, Lu SC, etal. Plasma homocysteine levels in Taiwanese vegetarians are higher than those of omnivores. J Nutr. 2002;132:152-158.
143. 12 deficiency and hyperhomocysteinemia in rural and urban Indians. J Assoc Physicians India. 2006;54:775-782.
144. Jacques PF, Bostom AG, Williams RR, etal. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
145. 12 vs placebo on mortality and major morbidity in myocardial infarction survivors. JAMA. 2010;303:2486-2494.
146. Pan Y, Guo LL, Cai LL, etal. Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomized, controlled trials. Br J Nutr. 2012;108:400-407.
147. Ingenbleek Y, Barclay D, Dirren H. Nutritional significance of alterations in serum amino acid patterns in goitrous patients. Am J Clin Nutr. 1986;43:310-319.
148. Ingenbleek Y, De Visscher M, De Nayer P. Measurement of prealbumin as index of protein-calorie malnutrition. Lancet. 1972;300:106-109.
149. Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease. Nutritional implications. Annu Rev Nutr. 1994;14:496-533.
150. Holt LE Jr, Snyderman SE, Norton PM, etal. The plasma aminogram in kwashiorkor. Lancet. 1963;282:1343-1348.
151. Ingenbleek Y, Luypaert B, De Nayer P. Nutritional status and endemic goitre. Lancet. 1980;315:388-392.
152. Battezatti A, Bertoli S, San Romerio A, etal. Body composition: an important determinant of homocysteine and methionine concentrations in healthy individuals. Nutr Metab Cardiovasc Dis. 2007;17:525-534.
153. Fuller MF, McWilliam R, Wang TC, etal. The optimum dietary amino acid pattern for growing pigs. 2. Requirements for maintenance and for tissue protein accretion. Br J Nutr. 1989;62:255-267.
154. Owens FN, Bergen WG. Nitrogen metabolism in ruminant animals: historical perspective, current understanding and future implications. J Anim Sci. 1983;57(Suppl 2):498-518.
155. Tang B, Mustafa A, Gupta S, etal. Methionine-deficient diet induces post-transcriptional downregulation of cystathionine β-synthase. Nutrition. 2010;26:1170-1175.
156. Elshorbagy AK, Valdivia-Garcia M, Refsum H, etal. Sulfur amino acids in methionine-restricted rats: hyperhomocysteinemia. Nutrition. 2010;26:1201-1204.
157. Park EI, Garrow TA. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J Biol Chem. 1999;274:7816-7824.
158. Millward DJ, Price GM, Pacy PJ, etal. Maintenance protein requirements: the need for conceptual re-evaluation. Proc Nutr Soc. 1990;49:473-487.
159. Abdel GA, Abdullah SH, Kordofani AY. Plasma homocysteine levels in cardiovascular disease, malaria and protein-energy malnutrition in Sudan. East Mediterr Health J. 2009;15:1432-1439.
160. Moyano D, Vilaseca MA, Artuch R, etal. Plasma total homocysteine in anorexia nervosa. Eur J Clin Nutr. 1998;52:172-175.
161. Gallistl S, Sudi KM, Erwa W, etal. Determinants of homocysteine during weight reduction in obese children and adolescents. Metabolism. 2001;50:1220-1223.
162. Sheu WH, Wu HS, Wang CW, etal. Elevated plasma homocysteine concentrations six months after gastroplasty in morbidly obese subjects. Intern Med. 2001;40:584-588.
163. Faintuch J, Matsuda M, Cruz ME, etal. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg. 2004;14:175-181.
164. Ingenbleek Y, Hardillier E, Jung L. Subclinical protein malnutrition is a determinant of hyperhomocysteinemia. Nutrition. 2002;18:40-46.
165. Richie JP Jr, Komninou D, Leutzinger Y, etal. Tissue glutathione and cysteine levels in methionine-restricted rats. Nutrition. 2004;20:800-805.
166. Jahoor F, Badaloo A, Reid M, etal. Sulfur amino acid metabolism in children with severe childhood undernutrition: cysteine kinetics. Am J Clin Nutr. 2006;84:1393-1399.
167. Cuthbertson DP. The distribution of nitrogen and sulphur in the urine during conditions of increased catabolism. Biochem J. 1931;25:236-244.
168. Bienvenu J, Monneret G, Fabien N, etal. The clinical usefulness of the measurement of cytokines. Clin Chem Lab Med. 2000;38:267-285.
169. Ingenbleek Y, Bernstein L. The stressful condition as a nutritionally dependent adaptive dichotomy. Nutrition. 1999;15:305-320.
170. Long CL, Birkhahn RH, Geiger JW, etal. Contribution of skeletal muscle protein in elevated rates of whole body protein catabolism in trauma patients. Am J Clin Nutr. 1981;34:1087-1093.
171. Arnold J, Campbell IT, Samuels TA, etal. Increased whole body protein breakdown predominates over increased whole body synthesis in multiple organ failure. Clin Sci. 1993;84:655-661.
172. Breitzkreuz R, Holm S, Pittack N, etal. Massive loss of sulfur in HIV infection. AIDS Res Hum Retroviruses. 2000;16:203-209.
173. 13C-methionine in patients with severe burn injury. J Trauma. 1993;35:1-7.
174. Malmezat T, Breuillé D, Pouyet C, etal. Methionine transsulfuration is increased during sepsis in rats. Am J Physiol. 2000;275:E1391-E1397.
175. Malmezat T, Breuillé D, Capitan P, etal. Glutathione turnover is increased during the acute phase of sepsis in rats. J Nutr. 2000;130:1239-1246.
176. Taoka S, Ohja S, Shan X, etal. Evidence for heme-mediated redox regulation of human cystathionine β-synthase activity. J Biol Chem. 1998;273:25179-25184.
177. Larsson J, Liljedahl SO, Mårtensson J, etal. Urinary excretion of sulfur amino acids and sulfur metabolites in burned patients receiving parenteral nutrition. J Trauma. 1982;22:656-663.
178. Turgan N, Boydak B, Habif S, etal. Plasma homocysteine levels in acute coronary syndromes. Jpn Heart J. 1999;40:729-736.
179. Yuzbasioglu MF, Ozkaya M, Cakal E, etal. Changes in plasma levels of homocysteine in patients with acute pancreatitits. JOP. 2008;9:357-361.
180. Schindler K, Zauner C, Buchmayer H, etal. High prevalence of hyperhomocysteinemia in critically ill patients. Crit Care Med. 2000;28:991-995.
181. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14:222-231.
182. Cummings DM, King DE, Mainous AG, etal. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular history in the general US population. Eur J Cardiovasc Prev Rehabil. 2006;13:180-185.
183. Pupim LB, Heimbürger O, Qureshi AR, etal. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int. 2005;68:2368-2374.
184. Chico A, Pérez A, Córdoba A, etal. Plasma homocysteine is related to albumin secretion rate in diabetic patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia. 1998;41:684-693.
185. Jager A, Kostense PJ, Nijpels G, etal. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol. 2001;21:74-81.
186. Mykkänen L, Zaccaro DJ, Wagenknecht LE, etal. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the Insulin Resistance Atherosclerosis Study. Diabetes. 1998;47:793-800.
187. Meigs JB, Jacques PF, Selhub J, etal. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes Care. 2001;24:1403-1410.
188. Arnadottir M, Hultberg B, Berg AL. Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy. Nephrol Dial Transplant. 2001;16:45-47.
189. Ingec M, Borekci B, Kadanali S. Elevated plasma homocysteine concentrations in severe preeclampsia and eclampsia. Tohoku J Exp Med. 2005;206:225-231.
190. Bernasconi E, Uhr M, Magenta L, etal. Homocysteinemia in HIV-infected patients treated with highly active antiretroviral therapy. AIDS. 2001;15:1081-1082.
191. Weinstein SJ, Ziegler RG, Selhub J, etal. Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control. 2001;12:317-324.
192. Gatt A, Makris A, Cladd H, etal. Hyperhomocysteinemia in women with advanced breast cancer. Int J Lab Hematol. 2007;29:421-425.
193. Sun CF, Haven TR, Wu TL, etal. Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker. Clin Chim Acta. 2002;321:55-62.
194. Roubenoff R, Dellaripa P, Nadeau MR, etal. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum. 1997;40:718-722.
195. Dhar M, Bellevue R, Brar S, etal. Mild hyperhomocysteinemia in adult patients with sickle cell disease: a common finding unrelated to folate and cobalamin status. Am J Hematol. 2004;76:114-120.
196. Chillemi R, Zappacosta B, Simporè J, etal. Hyperhomocysteinemia in acute Plasmodium falciparum malaria: an effect of host-parasite interaction. Clin Chim Acta. 2004;348:113-120.
197. 2S be the third endogenous gaseous transmitter? FASEB J. 2002;16:1792-1798.
198. Sen U, Basu P, Abe OA, etal. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol. 2009;297:F410-F419.
199. Elrod JW, Calvert JW, Morrison J, etal. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A. 2007;104:15560-15565.
200. Chang L, Geng B, Yu F, etal. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids. 2008;34:573-585.
201. Yonezawa D, Sekiguchi F, Miyamoto M, etal. A protective role of hydrogen sulfide against oxidative stress in rat gastric mucosal epithelium. Toxicology. 2007;241:11-18.
202. 2S, a neuromodulator and smooth muscle relaxant. Nutr Rev. 2004;62:348-353.
203. 2S biogenesis via alternative transsulfuration reactions. J Biol Chem. 2009;284:22457-22466.
204. Shibuya N, Tanaka M, Yoshida M, etal. 3-mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal. 2009;11:703-714.
205. Mikami Y, Shibuya N, Kimura Y, etal. Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem J. 2011;439:479-485.
206. Kimura H, Shibuya N, Kimura Y. Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid Redox Signal. 2012;17:45-57.
207. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids. 2011;41:113-121.
208. Kamoun P. Endogenous production of hydrogen sulfide in mammals. Amino Acids. 2004;26:243-254.
209. Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative
210. Enokido Y, Suzuki E, Iwasawa K, etal. Cystathionine β-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB J. 2005;19:1854-1856.
211. Ischii I, Akahoshi N, Yu X, etal. Murine cystathionine γ-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem J. 2004;381:113-123.
212. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun. 1997;237:527-531.
213. House JD, Brosnan ME, Brosnan JT. Characterization of homocysteine metabolism in the rat kidney. Biochem J. 1997;328:287-292.
214. Mancardi D, Penna C, Merlino A, etal. Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochim Biophys Acta. 2009;1787:864-872.
215. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996;16:1066-1071.
216. Zhao W, Zhang J, Lu Y, etal. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K (ATP) channel opener. EMBO J. 2001;20:6008-6016.
217. 2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun. 2004;313:362-368.
218. Klimmek O. The biological cycle of sulfur. Met Ions Biol Syst. 2005;5:105-130.
219. Vennesland BV, Castric PA, Conn EE, etal. Cyanide metabolism. Fed Proc. 1982;41:2639-2648.
220. Wood JL. Sulfane sulfur. Methods Enzymol. 1987;143:25-29.
221. Ogasawara Y, Isoda S, Tanabe S. Tissue and subcellular distribution of bound and acid-labile sulfur, and the enzymic capacity for sulfide production in the rat. Biol Pharm Bull. 1994;17:1535-1542.
222. Toohey JI. Sulphane sulphur in biological systems: a possible regulatory role. Biochem J. 1989;264:625-632.
223. Ishigami M, Hiraki K, Umemura K, etal. A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal. 2009;11:205-214.
224. Kimura H. Metabolic turnover of hydrogen sulfide. Front Physiol. 2012;3:1-3.
225. Bonomi F, Pagani S, Cerletti P, etal. Rhodanese-mediated sulfur transfer to succinate dehydrogenase. Eur J Biochem. 1977;72:17-24.
226. Pagani S, Galante YM. Interaction of rhodanese with mitochondrial NADH dehydrogenase. Biochim Biophys Acta. 1983;742:278-284.
227. Russell PJ, Conner J, Sisson S. Sulfur specifically inhibits adenylate kinase in assays for creatine kinase. Clin Chem. 1984;30:1555-1557.
228. Hargrove JL, Wichman RD. A cystine-dependent inactivator of tyrosine aminotransferase co-purifies with γ-cystathionase (cysteine desulfurase). J Biol Chem. 1987;262:7351-7357.
229. Searcy DG, Lee SH. Sulfur reduction by human erythrocytes. J Exp Zool. 1998;282:310-322.
230. Xia M, Chen L, Muh RW, etal. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther. 2009;329:1056-1062.
231. Monagan WJ, Garai F. Treatment of acute and chronic polyarthritis, arthritis deformans, and septicemias, with activated colloid sulfur. Med J Rec. 1924;120:24-26.
232. Fiorucci S, Distrutti E, Cirino G, etal. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology. 2006;131:259-271.
233. Goubern M, Andriamihaja M, Nübel T, etal. Sulfide, the first inorganic substrate for human cells. FASEB J. 2007;21:1699-1706.
234. Furne J, Springfield J, Koenig T, etal. Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa. Biochem Pharmacol. 2001;62:255-259.
235. Chen YH, Yao WZ, Geng B, etal. Endogenous hydrogen sulfide in patients with COPD. Chest. 2005;128:3205-3211.
236. Whiteman M, Moore PK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J Cell Mol Med. 2009;13:488-507.
237. Furne J, Saeed A, Levitt MD. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1479-R1485.
238. 2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1930-R1937.
239. Liu XQ, Liu XQ, Jiang P, etal. Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof. Zhonghua Yi Xue Za Zhi. 2008;88:2246-2249.
240. Chen L, Ingrid S, Ding YG, etal. Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J. 2007;120:389-393.
241. Sun NL, Xi Y, Yang SN, etal. Plasma hydrogen sulfide and homocysteine levels in hypertensive patients with different blood pressure levels and complications. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35:1145-1148.
242. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787-795.
243. Qu K, Lee SW, Bian JS, etal. Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int. 2007;52:155-165.
244. 2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal. 2009;11:25-33.
245. Lee SW, Hu YS, Hu LF, etal. Hydrogen sulphide regulates calcium homeostasis in microglial cells. Glia. 2006;54:116-124.
246. Hu LF, Wong PT, Moore PK, etal. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem. 2007;100:1121-1128.
247. 12 cells. Neurosci Res. 2010;68:241-249.
248. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ-lyase. Science. 2008;322:587-590.
249. Zanardo RC, Brancaleone V, Distrutti E, etal. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006;20:2118-2120.
250. Tang G, Wu L, Liang W, etal. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol. 2005;68:1757-1764.
251. Rinaldi L, Gobbi G, Pambianco M, etal. Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3. Lab Invest. 2006;86:391-397.
252. Papapetropoulos A, Pyriochou A, Altaany Z, etal. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A. 2009;106:21972-21977.
253. Bos EM, Leuvenink HG, Snijder PM, etal. Hydrogen sulfide-induced hypometabolism prevents ischemia/reperfusion injury. J Am Soc Nephrol. 2009;20:1901-1905.
254. Tripatara P, Patel NS, Collino M, etal. Generation of endogenous hydrogen sulfide by cystathionine γ-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest. 2008;88:1038-1048.
255. Sen U, Munjal C, Qipshidze N, etal. Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol. 2010;31:442-455.
256. Wallace JL, Dicay M, McKnight W, etal. Hydrogen sulfide enhances ulcer healing in rats. FASEB J. 2007;21:4070-4076.
257. Fiorucci S, Antonelli E, Distrutti E, etal. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology. 2005;129:1210-1224.
258. Liu H, Bai XB, Shi S, etal. Hydrogen sulfide protects from intestinal ischaemia-reperfusion induced injury in rats. J Pharm Pharmacol. 2009;61:207-212.
259. 2S in rat insulin-secreting cells and the underlying mechanism. J Physiol. 2005;569:519-531.
260. Tamizhselvi R, Moore PK, Bhatia M. Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells. J Cell Mol Med. 2007;11:315-326.
261. Kang K, Zhao M, Jiang H, etal. Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Liver Transpl. 2009;15:1306-1314.
262. Wei HL, Zhang CY, Jin HF, etal. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol Sin. 2008;29:670-679.
263. Fu Z, Liu X, Geng B, etal. Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sci. 2008;82:1196-1202.
264. Chen YH, Wu R, Geng B, etal. Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma. Cytokine. 2009;45:117-123.
265. Li X, Jin H, Bin G, etal. Endogenous hydrogen sulfide regulates pulmonary artery collagen remodeling in rats with high pulmonary blood flow. Exp Biol Med (Maywood). 2009;234:504-512.
266. Dowbrowski RA, Russell MJ, Olson KR. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol. 2004;286:R678-R685.
267. 2S-releasing drugs as pharmaceuticals. J Med Chem. 2010;53:6275-6286.
268. Toohey JI. Sulfur signaling: is the agent sulfide or sulfane? Anal Biochem. 2011;413:1-7.
269. Kim JJ, Ha AW, Kim HS, etal. Inorganic sulfur reduces the motility and invasion of MDA-MB-231 human breast cancer cells. Nutr Res Pract. 2011;5:375-380.
270. Lee J, Lee HJ, Park JD, etal. Anti-cancer activity of highly purified sulfur in immortalized and malignant human oral keratinocytes. Toxicol in Vitro. 2008;22:87-95.
271. Wallace JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci. 2007;28:501-505.
272. Steed MM, Tyagi SC. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox Signal. 2011;15:1927-1943.
273. Tisdale SL, Reneau RB Jr, Platou JS. Atlas of sulfur deficiency. In: Tabatabai MA, ed. Sulfur in Agriculture. Madison, WI: American Society of Agronomy, Crop Science Society of America, Soil Science Society of America; 1967:295-322. Monograph no. 27.
274. Khurana MPS, Sadana US, Bijay-Singh Sulfur-nutrition of crops in the Indo-Gangetic plains of South Asia. In: Jez JM, ed. Sulfur: A Missing Link between Soils, Crops and Nutrition. Madison, WI: American Society of Agronomy, Crop Science Society of America, Soil Science Society of America; 2008:11-24. Monograph 50.
275. Fox RL, Blair GJ. Plant responses to sulfur in tropical soils. In: Tabatabai MA, ed. Sulfur in Agriculture. Madison, WI: American Society of Agronomy, Crop Science Society of America, Soil Science Society of America; 1967:405-434. Monograph no. 27.
276. Galili GR, Amir R, Hoefgen R, etal. Improving the levels of essential amino acids and sulfur metabolites in plants. Biol Chem. 2005;386:817-831.
277. Li L, Hu BC, Gong SJ, etal. Homocysteine-induced caspase-3 activation by endoplasmic reticulum stress in endothelial progenitor cells from patients with coronary heart disease and healthy donors. Biosci Biotechnol Biochem. 2011;75:1300-1305.
278. Subbaiah PV. Biomarkers of oxidative stress in plasma and urine. In: Caroli S, Záray G, eds. Analytical Techniques for Clinical Chemistry: Methods and Applications. Hoboken, NJ: J. Wiley & Sons; 2012:555-594.
279. Vacek TP, Vacek JC, Tyagi SC. Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodeling. Arch Physiol Biochem. 2012;118:31-42.
280. Antony GM, Laxmaiah A. Human development, poverty, health & nutrition situation in India. Indian J Med Res. 2008;128:198-205.
281. Ghosh K, Khare A, Shetty S. Fasting plasma homocysteine levels are increased in young patients with acute myocardial infarction in Western India. Indian Heart J. 2007;59:242-245.
282. Kumar Y, Das R, Garewal G, etal. High prevalence of hyperhomocysteinemia in young population of North India - a potential risk factor for coronary heart disease? Thromb Res. 2009;123:800-802.
283. Christopher R, Nagaraja D, Shankar SK. Homocysteine and cerebral stroke in developing countries. Curr Med Chem. 2007;14:2393-2401.
284. Lee J, Heng D, Chia KS, etal. Risk factors and incident coronary heart disease in Chinese, Malay, and Asian Indian males: the Singapore Cardiovascular Cohort Study. Int J Epidemiol. 2001;30:983-988.
285. Singh RB, Niaz MA, Ghosh S, etal. Low fat intake and coronary artery disease in a population with higher prevalence of coronary artery disease: the Indian paradox. J Am Coll Nutr. 1998;17:342-350.
286. Ahmad U, Frossard PM. Coronary heart disease in South Asia: need to redefine risk. Int J Cardiol. 2006;107:289-290.
287. Koebnick C, Garcia AL, Dagnelie PC, etal. Long-term consumption of a raw food diet is associated with favorable serum LDL cholesterol and triglycerides but also with elevated plasma homocysteine and low HDL cholesterol. J Nutr. 2005;135:2372-2375.
288. Chandalia M, Abate N, Cabo-Chan AV Jr, etal. Hyperhomocysteinemia in Asian Indians living in the United States. J Clin Endocrinol Metab. 2003;88:1089-1095.
289. Key TJ, Appleby PN, Rosell MS. Health effects of vegetarian and vegan diets. Proc Nutr Soc. 2006;65:35-41.
290. Ingenbleek Y, Carpentier YA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res. 1985;55:91-101.
291. Férard G, Gaudias J, Bourguignat A, etal. C-reactive protein to transthyretin ratio for the early diagnosis and follow-up of postoperative infection. Clin Chem Lab Med. 2002;40:1334-1338.
292. Valachovičová M, Krajčovičová-Kudlačková M, Blažíček P, etal. No evidence of insulin resistance in normal weight vegetarians. A case control study. Eur J Nutr. 2006;45:52-54.
293. Ingenbleek Y. The oxidative stress of hyperhomocysteinemia results from reduced bioavailability of sulfur-containing reductants. Open Clin Chem J. 2011;4:34-44.